P27707 (DCK_HUMAN) Homo sapiens (Human)
Deoxycytidine kinase UniProtKBInterProSTRINGInteractive Modelling
260 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: F5CTF3
It is possible new templates exist for this target since these models were created.
Available Structures
58 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| S74E-R104M-D133A dCK variant in complex with L-deoxythymidine and UDP |
Heteromer | 95.8 | 2×UDP; 2×LLT; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the F2.4.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-… | homo-2-mer | 98.28 | 2×18V; 2×UDP; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0634 inhibitor | homo-2-mer | 98.26 | 2×UDP; 2×J29; 2×NA; | |||
| C4S dCK variant of dCK in complex with L-dC+ADP | homo-2-mer | 98.76 | 2×ADP; 2×LDC; | |||
| C4S dCK variant of dCK in complex with gemcitabine+ADP | homo-2-mer | 98.76 | 2×ADP; 2×GEO; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0345 inhibitor | homo-2-mer | 98.26 | 2×UDP; 2×JCM; 2×NA; | |||
| The structure of deoxycytidine kinase complexed with lamivudine and ADP. | homo-2-mer | 98.76 | 2×ADP; 2×3TC; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0624 inhibitor | homo-2-mer | 98.26 | 2×UDP; 2×J6M; 2×NA; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the F2.2.1 inhibitoR (2-[({2-[3-(2-FLUOROETHOXY)-… | homo-2-mer | 98.25 | 2×UDP; 4×1NO; | |||
| C4S dCK variant of dCK in complex with FTC+ADP | homo-2-mer | 98.76 | 2×ADP; 2×ETV; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0642 inhibitor | homo-2-mer | 98.26 | 2×J98; 2×UDP; 2×NA; | |||
| C4S dCK variant of dCK in complex with D-dC+ADP | homo-2-mer | 98.75 | 2×ADP; 2×DCZ; | |||
| Structure of human dCK complexed with 2'-Deoxycytidine and ADP, Space group C 2 2 21 | homo-2-mer | 100 | 2×ADP; 2×DCZ; | |||
| Human dCK complex with 5-Me dC and ADP | homo-2-mer | 98.7 | 2×ADP; 2×MCY; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0602 inhibitor | homo-2-mer | 98.25 | 2×UDP; 2×J5U; 2×NA; | |||
| S74E dCK in complex with 5-bromodeoxycytidine and UDP | homo-2-mer | 98.31 | 2×UDP; 2×5BT; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the F2.1.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-… | homo-2-mer | 98.28 | 4×1NM; 2×UDP; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0274 inhibitor | homo-2-mer | 98.25 | 2×UDP; 2×J9I; 2×NA; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 4 [1-[5-(4-{[(2,6-diaminopyrimidin-… | homo-2-mer | 98.26 | 4×2XJ; 2×UDP; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0325 inhibitor | homo-2-mer | 98.25 | 2×UDP; 2×JAQ; 2×NA; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with EdC and UDP | homo-2-mer | 98.28 | 2×UDP; 2×VVC; | |||
| The structure of deoxycytidine kinase complexed with troxacitabine and ADP. | homo-2-mer | 98.76 | 2×ADP; 2×LTT; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the F2.3.1 inhibitor (2-[({5-ETHYL-2-[3-(2-FLUORO… | homo-2-mer | 98.28 | 3×1NN; 2×UDP; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the dCKi2 inhibitor | homo-2-mer | 98.26 | 2×UDP; 2×J7W; 2×NA; | |||
| S74E-dCK mutant in complex with UDP | homo-2-mer | 98.29 | 2×UDP; | |||
| C4S-E247A dCK variant of dCK in complex with cladribine+ADP | homo-2-mer | 98.35 | 2×ADP; 2×CL9; | |||
| Crystal structure of dCK mutant C3S in complex with masitinib and UDP | homo-2-mer | 99.13 | 2×UDP; 1×G65; 1×DCM; | |||
| Structure of human dCK complexed with cytarabine and ADP-MG | homo-2-mer | 100.0 | 2×MG; 2×AR3; 2×ADP; | |||
| C4S dCK variant of dCK in complex with L-dA+UDP | homo-2-mer | 99.09 | 2×UDP; 2×3L1; | |||
| C4S dCK variant of dCK in complex with D-dA+UDP | homo-2-mer | 99.08 | 4×UDP; 2×3D1; | |||
| C4S dCK variant of dCK in complex with cladribine+UDP | homo-2-mer | 98.64 | 2×UDP; 2×CL9; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 10 {2-{[(1R/S)-1-{2-[3-(2-fluoroeth… | homo-2-mer | 98.27 | 2×2Y8; 2×2Y7; 2×UDP; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the dCKi1 inhibitor | homo-2-mer | 98.25 | 2×UDP; 4×JCA; 2×NA; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 6 {2-[5-(4-{[(4,6-diaminopyrimidin-… | homo-2-mer | 98.26 | 2×2XZ; 2×UDP; | |||
| Structure of human dCK complexed with gemcitabine and ADP-MG | homo-2-mer | 100.0 | 2×MG; 2×ADP; 2×GEO; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the DI-43 inhibitor | homo-2-mer | 98.27 | 2×1UX; 2×UDP; | |||
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0635 inhibitor | homo-2-mer | 98.25 | 2×UDP; 2×J7I; 2×NA; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 8 {2,2'-[{4-[(2R)-4-{[(4,6-diaminop… | homo-2-mer | 98.26 | 2×2XM; 2×UDP; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 9 {2-{[(1R)-1-{2-[3-(2-fluoroethoxy… | homo-2-mer | 98.27 | 2×2Y1; 2×UDP; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 5 {5-(4-{[(4,6-DIAMINOPYRIMIDIN-2-Y… | homo-2-mer | 98.25 | 2×2XL; 2×UDP; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the DI-39 inhibitor | homo-2-mer | 98.26 | 2×1QC; 2×UDP; | |||
| Human dCK complex with Acyclic Nucleoside | homo-2-mer | 98.7 | 2×AC2; 2×UDP; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 12R {N-{2-[5-(4-{(1R)-1-[(4,6-diami… | homo-2-mer | 98.27 | 2×UDP; 2×2XN; | |||
| C4S dCK variant of dCK in complex with L-dA+ADP | homo-2-mer | 98.68 | 2×MG; 2×3L1; 2×ADP; | |||
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 7 {N-(2-(3-(4-(((4,6-diaminopyrimid… | homo-2-mer | 98.25 | 2×2Y0; 2×UDP; | |||
| Structure of human dCK complexed with 2'-Deoxycytidine and ADP, P 43 21 2 space group | homo-2-mer | 100.0 | 2×ADP; 2×DCZ; | |||
| C4S-E247A dCK variant of dCK in complex with D-dA+ADP | homo-2-mer | 98.34 | 2×ADP; 2×3D1; | |||
| Crystal structure of human dCK R104M/D133A in complex with L-dT and ADP | homo-2-mer | 99.11 | 2×ADP; 2×LLT; | |||
| Crystal structure of human dCK complexed with clofarabine and ADP | homo-2-mer | 100.0 | 2×MG; 2×ADP; 2×CFB; | |||
| Crystal Structure of human deoxycytidine kinase in complex with deoxycytidine and uridine diphospha… | homo-2-mer | 100 | 1×CA; 2×MG; 2×DCZ; 2×UDP; | |||
| Crystal structure of human deoxycytidine kinase in complex with deoxycytidine | homo-2-mer | 100 | 1×CA; 2×DCZ; | |||
| Crystal structure of dCK mutant C3S in complex with imatinib and UDP | homo-2-mer | 99.13 | 2×UDP; 1×STI; 1×MG; 1×DCM; | |||
| Human Deoxycytidine kinase dCMP, UDP, Mg ion product complex | homo-2-mer | 100.0 | 2×MG; 2×UDP; 2×DCM; | |||
| Human Deoxycytidine kinase dAMP, UDP, Mg ion product complex | homo-2-mer | 100.0 | 2×MG; 2×UDP; 2×D5M; | |||
| Crystal structure of dCK mutant C3S | homo-2-mer | 99.14 | 2×UDP; 2×UMP; 2×MG; | |||
| C4S dCK variant of dCK in complex with D-dG+UDP | homo-2-mer | 98.56 | 2×GNG; 2×UDP; | |||
| X-Ray structure of Human Deoxycytidine Kinase in complex with ADP and an inhibitor | monomer | 100.0 | 1×ADP; 1×B86; 1×MG; | |||
| X-Ray structure of Human Deoxycytidine Kinase in complex with an inhibitor | monomer | 100.0 | 1×MLT; 2×B87; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2qrn.1.A | monomer | 0.82 | 1×MG; 1×UDP; 1×DCM; | 100.00 | ||